Gene expression profiling of intrahepatic cholangiocarcinoma.

Intrahepatic cholangiocarcinoma (ICC) is ranked as one of the top five causes of cancer-related deaths. ICC in Thai patients is associated with infection with the liver fluke, Opisthorchis viverrini, but the molecular basis for development remains unclear. The present study employed a microarray approach to compare gene expression profiles of ICCs and normal liver tissues from the same patients residing in Northeast Thailand, a region with a high prevalence of liver fluke infection. In ICC samples, 2,821 and 1,361 genes were found to be significantly up- and down-regulated respectively (unpaired t-test, p<0.05; fold-change>2.0). For validation of the microarray results, 7 up-regulated genes (FXYD3, GPRC5A, CEACAM5, MUC13, EPCAM, TMC5, and EHF) and 3 down- regulated genes (CPS1, TAT, and ITIH1) were selected for confirmation using quantitative RT-PCR, resulting in 100% agreement. The metallothionine heavy metal pathway contains the highest percentage of genes with statistically significant changes in expression. This study provides exon-level expression profiles in ICC that should be fruitful in identifying novel genetic markers for classifying and possibly early diagnosis of this highly fatal type of cholangiocarcinoma.

[1]  L. Gravitz.  Liver cancer , 2014, Nature.

[2]  L. Kowalski,et al.  HOXB7 expression is a prognostic factor for oral squamous cell carcinoma , 2012, Histopathology.

[3]  D. Aust,et al.  Hepatocyte Nuclear Factor (HNF) 4&agr; Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection , 2011, Annals of surgery.

[4]  V. Canzonieri,et al.  BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival , 2011, Head & neck.

[5]  C. Pilarsky,et al.  Hepatocyte Nuclear Factor (HNF) 4α Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection , 2011 .

[6]  X. Bian,et al.  HOXB7 as a Prognostic Factor and Mediator of Colorectal Cancer Progression , 2011, Clinical Cancer Research.

[7]  Y. Bayraktar,et al.  Cholangiocarcinoma: a compact review of the literature. , 2008, World journal of gastroenterology.

[8]  C. Pairojkul,et al.  Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.

[9]  Robin L. Jones,et al.  Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer , 2007, Breast Cancer Research and Treatment.

[10]  T. Patel,et al.  Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Yusuke Nakamura,et al.  Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma , 2006, Hepatology.

[12]  L. Kunkel,et al.  Loss of FilaminC (FLNc) Results in Severe Defects in Myogenesis and Myotube Structure , 2006, Molecular and Cellular Biology.

[13]  J. West,et al.  Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001 , 2006, British Journal of Cancer.

[14]  Yusuke Nakamura,et al.  Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma , 2005, Hepatology.

[15]  Il-Jin Kim,et al.  Microarray applications in cancer research. , 2004, Cancer research and treatment : official journal of Korean Cancer Association.

[16]  P. Pisani,et al.  Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand , 2004, Tropical medicine & international health : TM & IH.

[17]  A. Jayasurya,et al.  Metallothioneins in human tumors and potential roles in carcinogenesis. , 2003, Mutation research.

[18]  K. Lillemoe,et al.  Identification of novel cellular targets in biliary tract cancers using global gene expression technology. , 2003, The American journal of pathology.

[19]  K. Ghoshal,et al.  Suppression of metallothionein-I/II expression and its probable molecular mechanisms. , 2002, Environmental health perspectives.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  J. Hartwig,et al.  Filamins as integrators of cell mechanics and signalling , 2001, Nature Reviews Molecular Cell Biology.

[22]  S. Sikka,et al.  In vivo gene expression profile analysis of metallothionein in renal cell carcinoma. , 2000, Cancer letters.

[23]  N. Haboubi.  Pathology and genetics: Tumours of the digestive system , 2000 .

[24]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[25]  H. Thomas,et al.  Increase in primary liver cancer in the UK, 1979–94 , 1997, The Lancet.

[26]  James L. Winkler,et al.  Accessing Genetic Information with High-Density DNA Arrays , 1996, Science.

[27]  H. Esumi,et al.  Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection. , 1996, Carcinogenesis.

[28]  I. Hickson,et al.  Structure and function of type II DNA topoisomerases. , 1994, The Biochemical journal.

[29]  F. Stennard,et al.  Characterisation of six additional human metallothionein genes. , 1994, Biochimica et biophysica acta.

[30]  C. Pairojkul,et al.  Strong promoting effect of Opisthorchis viverrini infection on dimethylnitrosamine-initiated hamster liver. , 1994, Cancer letters.

[31]  H. Esumi,et al.  Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. , 1994, Mutation research.

[32]  D. Parkin,et al.  Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma , 1991, International journal of cancer.

[33]  C. E. Hildebrand,et al.  Human metallothionein genes: structure of the functional locus at 16q13. , 1990, Genomics.

[34]  T. Kuroishi,et al.  Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. , 1990, Japanese journal of clinical oncology.

[35]  T. Shows,et al.  Nomenclature for human homeobox genes. , 1990, Genomics.

[36]  M. Haswell-Elkins,et al.  Cholangiocarcinoma in north-east Thailand , 1990, The Lancet.

[37]  A. Lowenfels.  Opisthorchis viverrini infection and cholangiocarcinoma. , 1985, Gastroenterology.

[38]  W. Brockelman,et al.  Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study. , 1985, Gastroenterology.

[39]  D. Hamer,et al.  Structure and expression of two human metallothionein-I isoform genes and a related pseudogene. , 1985, The Journal of biological chemistry.

[40]  S Thameem Dheen,et al.  Metallothionein 2A expression is associated with cell proliferation in breast cancer. , 2002, Carcinogenesis.

[41]  A. Jayasurya,et al.  Analysis of Metallothionein Expression in Human Cancers , 2001 .

[42]  R. Goorha,et al.  The mouse mitotic checkpoint gene bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner. , 1999, Genomics.

[43]  C. Pairojkul,et al.  Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. , 1993, Carcinogenesis.

[44]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.